Normally, MCP-1 is higher in men than in women (Samnegård et al. 2009), which might partly explain gender differences in pathophysiological mechanisms of cardiovascular disease (Samnegård et al. 2009). This evidence concerns the gene CCL2 and cardiovascular disorder.